<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2AFC5CFA-103A-40EE-8058-B8A79D2095DA"><gtr:id>2AFC5CFA-103A-40EE-8058-B8A79D2095DA</gtr:id><gtr:name>MRC Human Genetics Unit</gtr:name><gtr:address><gtr:line1>Western General Hospital</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH4 2XU</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DFB423E1-0619-40EC-8CC6-E272A494EB7E"><gtr:id>DFB423E1-0619-40EC-8CC6-E272A494EB7E</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>FitzPatrick</gtr:surname><gtr:orcidId>0000-0003-4861-969X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127561093"><gtr:id>87A302AA-56E1-4E01-A4FA-C4BF4C91F136</gtr:id><gtr:title>Common congenital malformations in humans</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127561093</gtr:grantReference><gtr:abstractText>The development of a healthy baby from a single cell in only 280 days of human pregnancy depends on a complicated developmental plan that is under genetic control. In some babies the plan goes wrong and this results in a birth defect or malformation. Malformations are now the commonest cause of death in children under five years of age and the cause is still unknown in most cases.||The aim of my lab is to identify the genes responsible for several types of birth defect including cleft lip and/or cleft palate, small or absent eyes, and severe limb and kidney problems. We are helped by studying rare families with multiple affected individual or children who have unusual chromosome patterns that allow us to identify genes with a critical role in the development of particular human structures. We can then look for genetic changes in other children with the same condition to see how important the gene is as a cause of the condition.||Our aim is to build up a map of genes that are important in normal development of important parts of the body and ultimately to see if we can prevent birth defects occurring in the first place.</gtr:abstractText><gtr:technicalSummary>Malformations are the commonest cause of death in UK children under five years of age. The aetiology unknown in most cases. We aim to understand individual loci, mechanisms and interaction that the genetic basis of several different major malformations using samples from large cohorts of patients with; cleft lip and/or cleft palate, bilateral renal agenesis and eye malformations.||To identify new disease genes we utilise three main human genetics approaches:||Apparently balanced chromosomal rearrangements (ABCR)||This approach has been the mainstay of our gene identification work but has recently proven useful in developing techniques to look at long-range control of developmentally regulated genes. Recurrent breakpoints on 17q24 led us to characterise regulatory mutations more that 1.3 Mb centromeric and telomeric to SOX9 as a major cause of Pierre Robin sequence, an important subset of cleft palate. We have also identified ESRRG as a candidate gene for human renal agenesis.||Array-based comparative genomic hybridisation (aCGH) to identify microdeletions associated with specific malformations.||Overlapping deletions identified at 5q22 in five patients have identified a locus for Pierre Robin sequence on 5q close to the FBN2 gene.||Linkage analysis in families.||We have identified the locus for a rare but interesting human condition called ophthalmoacromelic syndrome (anophthalmia with oligodactyly) on 14q.||Many of the chromosomal abnormalities that we work on appear to be acting through disruption of cis-regulation of developmentally, dosage critical gene. We are continuing our work into the long-range control and developmental function of SATB2 as a cause of cleft palate. We have also been collaborating with Professor van Heyningen on identifying cis-regulatory mutations in PAX6 as a case of aniridia. As part of our P50 NIDCR-funded project we have also started taking a systematic approach to investigate the utility of developmental gene expression analysis in mouse embryos as a method of identifying disease genes.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-03-06</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3441018</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>DDD Project</gtr:description><gtr:id>CDA5EBB7-497A-4EEA-A419-3E04B80F7836</gtr:id><gtr:impact>This project aims to analyse 12000 children in the UK with developmental disorders.</gtr:impact><gtr:outcomeId>DzdC725SvRX-1</gtr:outcomeId><gtr:partnerContribution>This project will allow is to perform high resolution genetic analysis and exome sequencing on 600 local cases with different developmental disorders.</gtr:partnerContribution><gtr:piContribution>I am one of the six coapplicants on the grant and I am a member of the management committee</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Life Sciences</gtr:department><gtr:description>FaceBase</gtr:description><gtr:id>BCBD48A6-4D13-4374-93A4-1C1A8CF6BC72</gtr:id><gtr:impact>FaceBase database of craniofacial development</gtr:impact><gtr:outcomeId>1E158CEFE2E-1</gtr:outcomeId><gtr:partnerContribution>This been a very useful collaboration that has involved sharing of ideas and techniques to the benefit of both labs</gtr:partnerContribution><gtr:piContribution>We have performed high throughput analysis and integration of expression data during development of the face</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK10K</gtr:description><gtr:id>74EF6106-E785-4AB7-ADF9-6CC707B7A58A</gtr:id><gtr:impact>We obtained exome sequences from 128 individuals for the analysis of eye malformation</gtr:impact><gtr:outcomeId>fopK6wzzNyq-1</gtr:outcomeId><gtr:partnerContribution>This has funded exome sequencing on 100 coloboma cases</gtr:partnerContribution><gtr:piContribution>I have supplied clinical informaiton and samples on 100 cases of coloboma. I co-chair the rare disease subgroup of this project</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Platform Presentation at British Society for Human Genetics Sept 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5AE4C98E-1864-4F57-B2D2-1D36698265F9</gtr:id><gtr:impact>I present at many research meetings in the UK, this was to the plenary session of 500 BSHG delegates

Informal feedback only from audience members but also emails from potential collaborators</gtr:impact><gtr:outcomeId>7AD89687D9D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Director of the Cornelia de Lange Syndrome Foundation of UK and Ireland 2000-2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0552BE35-5529-46F8-B7A5-9D3ADA83DA64</gtr:id><gtr:impact>I attend each of the 6-monthly national meetings of the CdLS foundation and meet with parents and children frequently to give results from our research diagnostic analysis

We communicate research diagnostic results to individual families and their medical professionals</gtr:impact><gtr:outcomeId>37BC0826674</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.cdls.org.uk</gtr:url><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at the Short Course in Mammalian Experimental Genetics at the Jackson Labs, Bar Harbor, Maine 2011-2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BE9A9E41-212F-4B5C-A920-C5F7D1DA0036</gtr:id><gtr:impact>This a very prestigious course that is attended by many North American trainees and post docs in Human Genetics

This enabled me to speak about developmental disorders to an audience that represents the future of clinical genetics in the USA</gtr:impact><gtr:outcomeId>HFPgyZVVoUV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://www.jax.org/education-and-learning/education-calendar/2016/july/human-and-mammalian-genetics-and-genomics-the-57th-mckusick-short-course</gtr:url><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Talk to Indian Society for Human Genetics 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EAE79F3F-6D65-48A1-9F99-B0797DA844C7</gtr:id><gtr:impact>This was an invitation from Indian human geneticist for me to talk about the genetic basis of eye malformations

We have established excellent research collaborations with Indian paediatric geneticists</gtr:impact><gtr:outcomeId>KjJNwJPkVaw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>276428</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH NIDCR FaceBase Grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>A2A613FF-9020-4941-B468-64D6FB3049D6</gtr:id><gtr:outcomeId>BE757EA27620</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Deciphering Developmental Disorders</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Health Innovation Challenge Fund (HICF)</gtr:fundingOrg><gtr:id>77B2F11A-3341-4268-9743-903867D25A4B</gtr:id><gtr:outcomeId>m7Va1tfRmxz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>181000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH NIDCR Craniofacial Centre Grant</gtr:description><gtr:end>2007-09-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>3BE79B10-8975-4AE0-A4E1-B87546333148</gtr:id><gtr:outcomeId>682FD833F040</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>NIDCR FaceBase Hub Grant</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>29F16457-A358-4B19-BFAD-FFDA654080FE</gtr:id><gtr:outcomeId>FmcxnQQ3KhJ0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Genetics Forum Role in Learning Disability Diagnosis</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>530B139F-BA7A-4636-9418-126B29EF4156</gtr:id><gtr:outcomeId>D6046BAC81C</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SIGN Guidelines on Diagnosis and Treatment of Autistic Spectrum Disorders</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9E2DF7A-3CF9-4876-83EC-FE2EBA438646</gtr:id><gtr:impact>These guidelines provided clear evidence for the correct methods and provisions requires to provide an adequate diagnostic and management service for children and young people with Autistic Spectrum Disorders</gtr:impact><gtr:outcomeId>m65rxFuibMA</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We identified SOX2 as the major cauative gene in bilateral eye malformations causing blindness</gtr:description><gtr:id>A6F6FD99-5399-41D6-894B-84EB1C1A1813</gtr:id><gtr:impact>This test is now used throughout the world in DNA diagnostic laboratories.</gtr:impact><gtr:outcomeId>E9593268606</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>SOX2 as a major causative gene in bilateral eye malformations</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/books/NBK1300/?report=reader</gtr:url><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>This is a variant filtering tool which uses &amp;gt;2000 disease-gene pairs</gtr:description><gtr:id>818D6220-5FA3-4178-B837-8D18FDF80EBE</gtr:id><gtr:impact>This database is an important component of the Deciphering Developmental Disorders project</gtr:impact><gtr:outcomeId>58c822c2776ed1.60187926</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>DDG2P</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.ebi.ac.uk/gene2phenotype/disclaimer</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>MEPA cells are isolated from the mandibular or maxillary processes of embryonic mice carrying a temperature sensitive T-antigen. They express transcription factors that are critical to normal development of these structures</gtr:description><gtr:id>F94DBB9D-0511-4D0C-9249-613262598309</gtr:id><gtr:impact>These cells are crucial to the identification of mutations in specific regulatory sequences mutated in a subtype of cleft palate</gtr:impact><gtr:outcomeId>6ACD17D0496</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MEPA</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Panels of patient DNA for specific developmental eye defects.</gtr:description><gtr:id>C2E4B36B-D280-4F30-B526-A7ED5CC51C64</gtr:id><gtr:impact>Such collaboration allowed the identification of STRA6 as the gene for Matthew Woods syndrome.</gtr:impact><gtr:outcomeId>3464CB8D7C1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MEEM</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Collection of patients with Cornelia de Lange syndrome</gtr:description><gtr:id>92640437-1D5A-4D09-9D79-CFA98B8CDC2D</gtr:id><gtr:impact>WE have identified new mutations in NIPBL, SMC1A, HDAC8 and ANKRD11</gtr:impact><gtr:outcomeId>k6DVe3Jj3ve</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CdLS</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1A1E921A-2B84-460E-B12E-6967AB191F2C</gtr:id><gtr:title>WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6bbfee6ff1f80956ad25da722cca88f"><gtr:id>a6bbfee6ff1f80956ad25da722cca88f</gtr:id><gtr:otherNames>Suri M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>4BE1D99C945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A002C6A-5B57-4E7C-AEC1-B831FE0396B8</gtr:id><gtr:title>FRA2A is a CGG repeat expansion associated with silencing of AFF3.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ac4daf46fe50c1941d54df99d9622dd"><gtr:id>2ac4daf46fe50c1941d54df99d9622dd</gtr:id><gtr:otherNames>Metsu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>543bf0b1cb75d7.83721421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E33C014C-7E26-4231-AE59-E11F0AAEFEF2</gtr:id><gtr:title>Rare variants in NR2F2 cause congenital heart defects in humans.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700027c4ee9fdcba57eb130488c489ba"><gtr:id>700027c4ee9fdcba57eb130488c489ba</gtr:id><gtr:otherNames>Al Turki S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>543bf84f74fc05.41239160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8084E82F-4F02-4718-A1D8-F1CF5B2F0BD9</gtr:id><gtr:title>Xq28 duplication presenting with intestinal and bladder dysfunction and a distinctive facial appearance.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf9092783b31bfb38987a1f71be2f93"><gtr:id>fcf9092783b31bfb38987a1f71be2f93</gtr:id><gtr:otherNames>Clayton-Smith J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>A5415E2BB74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>454B16DD-4BE3-475A-8B1B-C94387FB8FFF</gtr:id><gtr:title>Heterozygous loss-of-function mutations in YAP1 cause both isolated and syndromic optic fissure closure defects.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8b057f36c63e21093af1f9fe1543281"><gtr:id>e8b057f36c63e21093af1f9fe1543281</gtr:id><gtr:otherNames>Williamson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>543bf0b202e8b6.13477833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B7BC7ED-BADE-46B0-B693-D1590D955152</gtr:id><gtr:title>Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a0625f0832b35560c1b3e72b8a4e09c"><gtr:id>7a0625f0832b35560c1b3e72b8a4e09c</gtr:id><gtr:otherNames>Kaiser FJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>543bf0b2513de5.66772997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30932853-E698-4F7B-8DAD-2D7D166AFEDE</gtr:id><gtr:title>A trans-acting protein effect causes severe eye malformation in the Mp mouse.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20eee06f2065edac7c2a2235ff25b9b7"><gtr:id>20eee06f2065edac7c2a2235ff25b9b7</gtr:id><gtr:otherNames>Rainger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>543bf1afecad75.85965579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C8EBE99-CB4D-4016-84DF-CFB71502CB77</gtr:id><gtr:title>Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting.</gtr:title><gtr:parentPublicationTitle>Cytogenetic and genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cce18583c99005a4a7ac4cbbf6f04a4"><gtr:id>5cce18583c99005a4a7ac4cbbf6f04a4</gtr:id><gtr:otherNames>Goobie S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1424-8581</gtr:issn><gtr:outcomeId>2FD52C92D33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C7631E2-9793-46BA-BA01-6F266B689B91</gtr:id><gtr:title>'Crommelin-type' symmetrical tetramelic reduction deformity: a new case and breakpoint mapping of a reported case with de-novo t(2;12)(p25.1;q23.3).</gtr:title><gtr:parentPublicationTitle>Clinical dysmorphology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74c48e336383f01d4f6b0c6a8be512a6"><gtr:id>74c48e336383f01d4f6b0c6a8be512a6</gtr:id><gtr:otherNames>Harewood L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0962-8827</gtr:issn><gtr:outcomeId>QNwmS9qDpUa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4636970-A7FC-4C09-90D4-D5F8B3734327</gtr:id><gtr:title>CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc69a02f130b88e6592620a33626715"><gtr:id>0fc69a02f130b88e6592620a33626715</gtr:id><gtr:otherNames>Winnepenninckx B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>E40AA1E7D87</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFBAE32B-2AB5-4147-9514-558D8D1B150F</gtr:id><gtr:title>Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2797a4c65bd31913508a5589a208090b"><gtr:id>2797a4c65bd31913508a5589a208090b</gtr:id><gtr:otherNames>Southgate L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>GrQMwJ6A3Zj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F20C672-0504-4660-979F-52B49B6F2532</gtr:id><gtr:title>Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3784d78d3478a34fa3c5d3ed2d31375b"><gtr:id>3784d78d3478a34fa3c5d3ed2d31375b</gtr:id><gtr:otherNames>Akawi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56a0e495df03a2.74045013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C4E4AF4-243E-4E27-96C6-9FC61801E922</gtr:id><gtr:title>Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD): postmortem analysis of 45 cases with breakpoint mapping of two de novo translocations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74c48e336383f01d4f6b0c6a8be512a6"><gtr:id>74c48e336383f01d4f6b0c6a8be512a6</gtr:id><gtr:otherNames>Harewood L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>sjvjMnv3rnD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5B9AA7C-BA20-4967-8486-B5C0DF03025A</gtr:id><gtr:title>Folate and clefts of the lip and palate--a U.K.-based case-control study: Part II: Biochemical and genetic analysis.</gtr:title><gtr:parentPublicationTitle>The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e0d3ba463e9e5b70b1ae7e37a30b834"><gtr:id>4e0d3ba463e9e5b70b1ae7e37a30b834</gtr:id><gtr:otherNames>Little J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1055-6656</gtr:issn><gtr:outcomeId>80028A2E574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42E55C21-515F-4CC4-A46F-758B03D6BA75</gtr:id><gtr:title>Warburg Micro syndrome is caused by RAB18 deficiency or dysregulation.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f06be73dbf095332a448a6508298737"><gtr:id>8f06be73dbf095332a448a6508298737</gtr:id><gtr:otherNames>Handley MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>56a789c53c5438.59367298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7277583A-4580-47CA-BDA4-7D16507F74EF</gtr:id><gtr:title>Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg Anophthalmia) syndrome in humans and mice.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20eee06f2065edac7c2a2235ff25b9b7"><gtr:id>20eee06f2065edac7c2a2235ff25b9b7</gtr:id><gtr:otherNames>Rainger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>fQ3GWpr5tNZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88708970-245F-4A96-AFEF-B68DB337EAC1</gtr:id><gtr:title>The 12q14 microdeletion syndrome: six new cases confirming the role of HMGA2 in growth.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4518640286a844999b7371440acc6fa5"><gtr:id>4518640286a844999b7371440acc6fa5</gtr:id><gtr:otherNames>Lynch SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>P1hJAgKrW8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B0DFCA3-F7D5-4344-BC10-8A29544C94C2</gtr:id><gtr:title>A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction.</gtr:title><gtr:parentPublicationTitle>Molecular vision</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3fa79c8b3835e52b0c1533a35386488"><gtr:id>b3fa79c8b3835e52b0c1533a35386488</gtr:id><gtr:otherNames>Henderson RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1090-0535</gtr:issn><gtr:outcomeId>FAA6D7FEA39</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5736AC2B-5C29-42D7-8041-1AE714573D4F</gtr:id><gtr:title>Beckwith-Wiedemann-like macroglossia and 18q23 haploinsufficiency.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e06b0f4cd79795015826dafb945ef542"><gtr:id>e06b0f4cd79795015826dafb945ef542</gtr:id><gtr:otherNames>Lirussi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>A46045BCEB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03C2BD47-3EF3-4F6A-9EAA-EDC6FF0DCB57</gtr:id><gtr:title>Rare Variants in NR2F2 Cause Congenital Heart Defects in Humans</gtr:title><gtr:parentPublicationTitle>The American Journal of Human Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac5d05cde71482375f940a8ed447c889"><gtr:id>ac5d05cde71482375f940a8ed447c889</gtr:id><gtr:otherNames>Al?Turki S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>543bf84fb0cb77.92292030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DD0A184-0DB3-41BC-A550-3ED38474812C</gtr:id><gtr:title>Decreased cholesterol synthesis as a possible aetiological factor in malformations of trisomy 18.</gtr:title><gtr:parentPublicationTitle>European journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0919a3f85fb41b4000a8bd43b8ce1f29"><gtr:id>0919a3f85fb41b4000a8bd43b8ce1f29</gtr:id><gtr:otherNames>Lam WW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1769-7212</gtr:issn><gtr:outcomeId>30D57D8F16F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FA9A1D7-4A9F-4F0A-942A-04FE113D0BAF</gtr:id><gtr:title>Human-specific gain of function in a developmental enhancer.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c55645ca1b26e67b6117770fdaeab11"><gtr:id>7c55645ca1b26e67b6117770fdaeab11</gtr:id><gtr:otherNames>Prabhakar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>397A4B70D73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99CC3B6B-00D1-497C-A73B-EDEB6C025A2B</gtr:id><gtr:title>Role of SOX2 mutations in human hippocampal malformations and epilepsy.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/720f44ce167f75a03764bbcbbeb1ee3d"><gtr:id>720f44ce167f75a03764bbcbbeb1ee3d</gtr:id><gtr:otherNames>Sisodiya SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>AADB0B87EA3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EA2E18C-03B5-4823-8148-3DDD69A10806</gtr:id><gtr:title>BCOR analysis in patients with OFCD and Lenz microphthalmia syndromes, mental retardation with ocular anomalies, and cardiac laterality defects.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11a31910a06bb20d9c132d2dee95cef3"><gtr:id>11a31910a06bb20d9c132d2dee95cef3</gtr:id><gtr:otherNames>Hilton E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>4636736B3F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA569D3E-8F25-4207-9D5C-3D29BECA93C1</gtr:id><gtr:title>Disruption of ST5 is associated with mental retardation and multiple congenital anomalies.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73bacab2e8606b37c904c82a19c14aaf"><gtr:id>73bacab2e8606b37c904c82a19c14aaf</gtr:id><gtr:otherNames>G?hring I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>E4E17F7A419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB8E4D5A-7855-4FFA-B5AF-98B4D0BFCF2E</gtr:id><gtr:title>FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2664ba53dc0747bf05e191dd0c9ce9b"><gtr:id>c2664ba53dc0747bf05e191dd0c9ce9b</gtr:id><gtr:otherNames>Fantes JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>53ABF699583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50A9DD65-6B84-4413-AF65-13BE4AF4BF03</gtr:id><gtr:title>Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a7a9d5df3497cc3cb4f59918b74bd13"><gtr:id>0a7a9d5df3497cc3cb4f59918b74bd13</gtr:id><gtr:otherNames>Pasutto F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>187F639C859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EAB4720-C611-4239-B2C9-D242F9545F50</gtr:id><gtr:title>Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25e8a4c7692e8f60c2e1d499914976e6"><gtr:id>25e8a4c7692e8f60c2e1d499914976e6</gtr:id><gtr:otherNames>Boland E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>766E656BE78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BC281A5-872B-425F-9394-87C05AF579DD</gtr:id><gtr:title>Status dystonicus in two patients with SOX2-anophthalmia syndrome and nonsense mutations.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a4e7d9d83ed03c733e22fec10c3820f"><gtr:id>2a4e7d9d83ed03c733e22fec10c3820f</gtr:id><gtr:otherNames>Gorman KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>582b202466b6a3.92446730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>149AB25F-0C9F-40C5-879D-74FE55421BE7</gtr:id><gtr:title>Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e74df0c81b427090e2f5257f07964a2"><gtr:id>4e74df0c81b427090e2f5257f07964a2</gtr:id><gtr:otherNames>Kline AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>2C3A5100624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6DB9DAD-9A2C-4811-8921-46884472F813</gtr:id><gtr:title>De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/635a3c5dbfe2738adddc7dfea8fe7535"><gtr:id>635a3c5dbfe2738adddc7dfea8fe7535</gtr:id><gtr:otherNames>Parker MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>56a0e5d681a657.59755908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9729E33-5BE1-45ED-88E8-8B531C72804C</gtr:id><gtr:title>Fine tuning of craniofacial morphology by distant-acting enhancers.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afd8b3a2bb589d29f39d41f07dedad41"><gtr:id>afd8b3a2bb589d29f39d41f07dedad41</gtr:id><gtr:otherNames>Attanasio C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_14821_21_24159046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4CCED63-1205-4902-A357-54F2BB96650D</gtr:id><gtr:title>Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89fb8cc5be24acbc477877032916faaa"><gtr:id>89fb8cc5be24acbc477877032916faaa</gtr:id><gtr:otherNames>Benko S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>CF26FF8AB55</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92D568CB-4BD9-4713-B5BE-E16807154D81</gtr:id><gtr:title>Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf78972f5de4dacb7cdfb7477da0301f"><gtr:id>bf78972f5de4dacb7cdfb7477da0301f</gtr:id><gtr:otherNames>Kalscheuer VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>E3958DC8FD4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEE382BF-59BD-4DCA-B2A4-D4607CF27A64</gtr:id><gtr:title>Filling in the gaps in cranial suture biology.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff7855c93ca9cf3d8dc123a53d8d988b"><gtr:id>ff7855c93ca9cf3d8dc123a53d8d988b</gtr:id><gtr:otherNames>Fitzpatrick DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14821_21_23438589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A131505-0E9E-49C2-BE4A-8D52DCC350E6</gtr:id><gtr:title>Miller (Genee-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20eee06f2065edac7c2a2235ff25b9b7"><gtr:id>20eee06f2065edac7c2a2235ff25b9b7</gtr:id><gtr:otherNames>Rainger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14821_21_22692683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F388C4-F866-4F21-956A-F9BA801452B5</gtr:id><gtr:title>Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center.</gtr:title><gtr:parentPublicationTitle>Molecular genetics &amp; genomic medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aacb6345248d3b744de300a8d5c789f5"><gtr:id>aacb6345248d3b744de300a8d5c789f5</gtr:id><gtr:otherNames>Gerth-Kahlert C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2324-9269</gtr:issn><gtr:outcomeId>543bf1afb996b4.79106930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>705E786E-C866-4AB9-951D-1C023447FA42</gtr:id><gtr:title>SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977df90660e78bb470906ca51984d8c9"><gtr:id>977df90660e78bb470906ca51984d8c9</gtr:id><gtr:otherNames>Shaw ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58a471343f8291.89767988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6CA92BE-1E5E-4434-AC2B-58703B362C65</gtr:id><gtr:title>Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8b057f36c63e21093af1f9fe1543281"><gtr:id>e8b057f36c63e21093af1f9fe1543281</gtr:id><gtr:otherNames>Williamson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5ED3B995FB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30B88AEB-ECFA-4ECD-9DFA-2CCF3059308F</gtr:id><gtr:title>Recurrence of SOX2 anophthalmia syndrome with gonosomal mosaicism in a phenotypically normal mother.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a69662addf9f74ee3ca92cdc7d9398ca"><gtr:id>a69662addf9f74ee3ca92cdc7d9398ca</gtr:id><gtr:otherNames>Faivre L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>7C1077BE3FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E66C473-2595-47B6-85BD-DC2BA306FC53</gtr:id><gtr:title>Anophthalmia and microphthalmia.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7967e55ffc46b734d83a1d158b45d663"><gtr:id>7967e55ffc46b734d83a1d158b45d663</gtr:id><gtr:otherNames>Verma AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>34DB1FD3232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00FF99A8-0EF8-4C83-A7BB-0F686CAC8714</gtr:id><gtr:title>A Restricted Repertoire of De Novo Mutations in ITPR1 Cause Gillespie Syndrome with Evidence for Dominant-Negative Effect.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6a9f54b6d97bf813b9b92499f28820d"><gtr:id>d6a9f54b6d97bf813b9b92499f28820d</gtr:id><gtr:otherNames>McEntagart M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>582b1e8ba72ed5.32481282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4CB200A-11CF-40E2-8B50-4BBFE451E53D</gtr:id><gtr:title>A secreted WNT-ligand-binding domain of FZD5 generated by a frameshift mutation causes autosomal dominant coloboma.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7a1e6c1d76e70702a15effb81f63589"><gtr:id>b7a1e6c1d76e70702a15effb81f63589</gtr:id><gtr:otherNames>Liu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56dc8673dcfc08.09592989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB156D1D-4BD8-4942-A593-CECDD8A6C24B</gtr:id><gtr:title>Folate and clefts of the lip and palate--a U.K.-based case-control study: Part I: Dietary and supplemental folate.</gtr:title><gtr:parentPublicationTitle>The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e0d3ba463e9e5b70b1ae7e37a30b834"><gtr:id>4e0d3ba463e9e5b70b1ae7e37a30b834</gtr:id><gtr:otherNames>Little J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1055-6656</gtr:issn><gtr:outcomeId>724D498F3D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>060ED63D-2BE6-4E0C-98CA-00C9F2C5DD9B</gtr:id><gtr:title>FRA18C: a new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcbc31c5823fb618bda6cad361e8c7c1"><gtr:id>bcbc31c5823fb618bda6cad361e8c7c1</gtr:id><gtr:otherNames>Debacker K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>8F70B37DC8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B6A916A-0910-4DCC-9F92-F250F33F308B</gtr:id><gtr:title>The molecular basis of the folate-sensitive fragile site FRA11A at 11q13.</gtr:title><gtr:parentPublicationTitle>Cytogenetic and genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcbc31c5823fb618bda6cad361e8c7c1"><gtr:id>bcbc31c5823fb618bda6cad361e8c7c1</gtr:id><gtr:otherNames>Debacker K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1424-8581</gtr:issn><gtr:outcomeId>A236924C6B4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CD3F27D-239D-451C-A9B1-130D9BC74AEF</gtr:id><gtr:title>Expansion of ocular phenotypic features associated with mutations in ADAMTS18.</gtr:title><gtr:parentPublicationTitle>JAMA ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bac50221dc503170820594fbe6ef3a1b"><gtr:id>bac50221dc503170820594fbe6ef3a1b</gtr:id><gtr:otherNames>Chandra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6165</gtr:issn><gtr:outcomeId>543bf0b1680a19.91615858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>642E70BF-F16F-4309-BD22-9841672A49B0</gtr:id><gtr:title>Long-range regulation at the SOX9 locus in development and disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2c6056e37d88d151a553a76ab933a92"><gtr:id>c2c6056e37d88d151a553a76ab933a92</gtr:id><gtr:otherNames>Gordon CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>44195B9B454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAA92A0B-796B-4F4B-81FC-30381D2E4E62</gtr:id><gtr:title>Genetic Analysis of 'PAX6-Negative' Individuals with Aniridia or Gillespie Syndrome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3982d000592c7bb3d227998a20f0c93b"><gtr:id>3982d000592c7bb3d227998a20f0c93b</gtr:id><gtr:otherNames>Ansari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>582b1f6364d9a6.55116877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE9666EF-2687-4F77-B347-2C9E9CDA2564</gtr:id><gtr:title>An atypical facial appearance and growth pattern in a child with Cornelia de Lange Syndrome: an intragenic deletion predicting loss of the N-terminal region of NIPBL.</gtr:title><gtr:parentPublicationTitle>Clinical dysmorphology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6892d496fb7cfc02f1e5c03661cddd5"><gtr:id>e6892d496fb7cfc02f1e5c03661cddd5</gtr:id><gtr:otherNames>Murray JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0962-8827</gtr:issn><gtr:outcomeId>AP2hNHcYgdB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC5D402B-E1FA-476A-BD79-1D78F0197DF6</gtr:id><gtr:title>Enhancer-adoption as a mechanism of human developmental disease.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef904b37590f6ea9122349a5769cd49d"><gtr:id>ef904b37590f6ea9122349a5769cd49d</gtr:id><gtr:otherNames>Lettice LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>gGzp6wghWFU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>945B17A5-68B2-41CA-AE61-0B34F28BF419</gtr:id><gtr:title>Clinical and molecular genetic features of ARC syndrome.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/548583dc7289807c625179646b47bf5d"><gtr:id>548583dc7289807c625179646b47bf5d</gtr:id><gtr:otherNames>Gissen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>62E808B5571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49F5ED72-702E-495A-A15D-2D5E40FBCDE8</gtr:id><gtr:title>Cornelia de Lange syndrome: extending the physical and psychological phenotype.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a676c3d6bcb48c09a778570bbcfeb075"><gtr:id>a676c3d6bcb48c09a778570bbcfeb075</gtr:id><gtr:otherNames>Oliver C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>tGQmhofBbhE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B463EC29-4E3B-4956-BB24-17B04CABECD2</gtr:id><gtr:title>Disruption of SATB2 or its long-range cis-regulation by SOX9 causes a syndromic form of Pierre Robin sequence.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2157c0ff75d4639ac1fc8dba3d100bfe"><gtr:id>2157c0ff75d4639ac1fc8dba3d100bfe</gtr:id><gtr:otherNames>Rainger JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>543bf0b2882f37.40100509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1708CEBD-A7D3-4785-BC88-97D71AD12E88</gtr:id><gtr:title>A Novel Oculo-Skeletal syndrome with intellectual disability caused by a particular MAB21L2 mutation.</gtr:title><gtr:parentPublicationTitle>European journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c249d3e17b05d1a4c11c871d0bd373d5"><gtr:id>c249d3e17b05d1a4c11c871d0bd373d5</gtr:id><gtr:otherNames>Horn D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1769-7212</gtr:issn><gtr:outcomeId>56a0c7af006991.71082408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B13B6A5C-507A-49E5-AA2B-BD26448211ED</gtr:id><gtr:title>Mutations in CEP57 cause mosaic variegated aneuploidy syndrome.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/993d22cedb6d8f5effbd6baf47d7b27c"><gtr:id>993d22cedb6d8f5effbd6baf47d7b27c</gtr:id><gtr:otherNames>Snape K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>hZXnFaaxAuE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>770FE4DF-6EDF-44D3-8CAA-CCC957EBE939</gtr:id><gtr:title>The genetic architecture of microphthalmia, anophthalmia and coloboma.</gtr:title><gtr:parentPublicationTitle>European journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8b057f36c63e21093af1f9fe1543281"><gtr:id>e8b057f36c63e21093af1f9fe1543281</gtr:id><gtr:otherNames>Williamson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1769-7212</gtr:issn><gtr:outcomeId>543bf0b196f0c3.06931321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AACA0A2-C50C-4E32-835E-E205F825999E</gtr:id><gtr:title>Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de477f914397a135e8b135bfff9b95e"><gtr:id>9de477f914397a135e8b135bfff9b95e</gtr:id><gtr:otherNames>Rahimov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>02FBF8B98CD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127561093</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>